AJHG

Mitchell Machiela, ScD, MPH, is an Earl Stadtman Investigator in the Integrative Tumor Epidemiology Branch at the National Cancer Institute.

Inside AJHG: A Chat with Mitchell Machiela

Inside AJHG: A Chat with Mitchell Machiela KS: What motivated you to start working on this project? MM: Our main motivation for this study was to better understand how germline genetic variation in the 6p25.1 Ewing sarcoma (EwS) susceptibility locus contributes to EwS risk. Specifically, based on evidence from a prior investigation of the 10q21.3... Read More

Renee Geck, PhD

Inside AJHG: A Chat with Renee Geck

Posted By: Kylee Spencer, PhD, Assistant Editor, AJHG KS: What prompted you to start working on this project?  RG: I needed to find some G6PD variants with a range of activities for an experiment I was planning. As I was reading the literature, I was finding reviews and following the trails back to the original... Read More

Inside AJHG: A Chat with Paul Lockhart, PhD

Inside AJHG: A Chat with Paul Lockhart, PhD

Posted By: Kylee Spencer, PhD, Assistant Editor, AJHG KS: What motivated you to start working on this project? PL: My background is the study of the causes and mechanisms of neurogenetic conditions. A part of this has been the identification of novel genetic mechanisms causing ataxia, a condition where individuals have impaired balance and coordination.... Read More

Recognizing Early-Career Excellence at the ASHG Journals

Sara Cullinan, PhD, Director of Scientific Publications Many ASHG members are familiar with the Cotterman Award, an honor bestowed each year to the trainee authors whose work published in The American Journal of Human Genetics (AJHG) is noted for exceptional quality. This year, Human Genetics and Genomics Advances (HGG Advances) introduced the Early-Career Investigator Award... Read More

Samuli Ripatti, PhD is a Professor of Biometry in the Institute for Molecular Medicine Finland at the University of Helsinki.

Inside AJHG: A Chat with Samuli Ripatti

Posted By: Kylee Spencer, PhD, Assistant Editor, AJHG KS: What prompted you to start working on this project?  SR: When discussing the potential clinical utility of polygenic risk scores, a typical question from the audience is, “Why bother testing your genetic risk profile when the role of genetic risk can simply be measured using a... Read More

ASHG uses cookies to provide you with a secure and custom web experience. Privacy Policy